Sfoglia per Autore
Evaluation of Extrauterine Head Growth From 14-21 days to Discharge With Longitudinal Intergrowth-21st Charts: A New Approach to Identify Very Preterm Infants at Risk of Long-Term Neurodevelopmental Impairment
2020-01-01 Maiocco G.; Migliaretti G.; Cresi F.; Peila C.; Deantoni S.; Trapani B.; Giuliani F.; Bertino E.; Coscia A.
The “fortilat” randomized clinical trial follow-up: Auxological outcome at 18 months of age
2020-01-01 Peila C.; Spada E.; Bertino E.; Deantoni S.; Percivati F.; Moro G.E.; Giribaldi M.; Cavallarin L.; Cresi F.; Coscia A.
The "Fortilat" Randomized Clinical Trial Follow-Up: Neurodevelopmental Outcome at 18 Months of Age
2020-01-01 Peila, Chiara; Spada, Elena; Deantoni, Sonia; Iuliano, Ester; Moro, Guido E; Giribaldi, Marzia; Cavallarin, Laura; Cresi, Francesco; Coscia, Alessandra
Replication properties and immunomodulatory effects of human cytomegalovirus infection impact the clinical presentation in congenital patients: A case series
2023-01-01 Alessia Spadavecchia, Francesco Cresi, Agata Leone, Valentina Dell'Oste, Matteo Biolatti, Ganna Galitska, Alessandra Coscia, Sonia Deantoni, Cinzia Valenza, Enrico Bertino, Chiara Peila
The Use of a Novel Donkey Milk-Derived Human Milk Fortified in the Neonatal Period Had No Effect on the Frequency of Allergic Manifestations During the First Years of Life: The “Fortilat Trial” Follow-Up
2024-01-01 Peila, Chiara; Spada, Elena; Deantoni, Sonia; Borsani, Matteo; Asteggiano, Monica; Chiale, Federica; Moro, Guido E.; Giribaldi, Marzia; Cavallarin, Laura; Cortinovis, Ivan; Coscia, Alessandra
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Evaluation of Extrauterine Head Growth From 14-21 days to Discharge With Longitudinal Intergrowth-21st Charts: A New Approach to Identify Very Preterm Infants at Risk of Long-Term Neurodevelopmental Impairment | 2020 | Maiocco G.; Migliaretti G.; Cresi F.; Peila C.; Deantoni S.; Trapani B.; Giuliani F.; Bertino E.; Coscia A. | |
| The “fortilat” randomized clinical trial follow-up: Auxological outcome at 18 months of age | 2020 | Peila C.; Spada E.; Bertino E.; Deantoni S.; Percivati F.; Moro G.E.; Giribaldi M.; Cavallarin L.; Cresi F.; Coscia A. | |
| The "Fortilat" Randomized Clinical Trial Follow-Up: Neurodevelopmental Outcome at 18 Months of Age | 2020 | Peila, Chiara; Spada, Elena; Deantoni, Sonia; Iuliano, Ester; Moro, Guido E; Giribaldi, Marzia; Cavallarin, Laura; Cresi, Francesco; Coscia, Alessandra | |
| Replication properties and immunomodulatory effects of human cytomegalovirus infection impact the clinical presentation in congenital patients: A case series | 2023 | Alessia Spadavecchia, Francesco Cresi, Agata Leone, Valentina Dell'Oste, Matteo Biolatti, Ganna Galitska, Alessandra Coscia, Sonia Deantoni, Cinzia Valenza, Enrico Bertino, Chiara Peila | |
| The Use of a Novel Donkey Milk-Derived Human Milk Fortified in the Neonatal Period Had No Effect on the Frequency of Allergic Manifestations During the First Years of Life: The “Fortilat Trial” Follow-Up | 2024 | Peila, Chiara; Spada, Elena; Deantoni, Sonia; Borsani, Matteo; Asteggiano, Monica; Chiale, Federica; Moro, Guido E.; Giribaldi, Marzia; Cavallarin, Laura; Cortinovis, Ivan; Coscia, Alessandra |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile